Discounted Cash Flow (DCF) Analysis Levered
Global Medical REIT Inc. (GMRE)
$10.53
-0.01 (-0.09%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 53.19 | 70.73 | 93.73 | 115.94 | 137.28 | 174.21 | 221.07 | 280.53 | 355.99 | 451.75 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | 24.83 | 36.43 | 34.52 | 68.97 | 76.54 | 87.20 | 110.65 | 140.41 | 178.18 | 226.11 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -180.84 | -256.81 | -218.79 | -201.66 | -156.20 | -426.54 | -541.27 | -686.87 | -871.62 | -1,106.08 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -156 | -220.38 | -184.27 | -132.69 | -79.66 | -339.35 | -430.62 | -546.45 | -693.44 | -879.97 |
Weighted Average Cost Of Capital
| Share price | $ 10.53 |
|---|---|
| Beta | 1.152 |
| Diluted Shares Outstanding | 65.46 |
| Cost of Debt | |
| Tax Rate | 126.18 |
| After-tax Cost of Debt | -1.11% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 9.692 |
| Total Debt | 694.12 |
| Total Equity | 689.31 |
| Total Capital | 1,383.43 |
| Debt Weighting | 50.17 |
| Equity Weighting | 49.83 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 53.19 | 70.73 | 93.73 | 115.94 | 137.28 | 174.21 | 221.07 | 280.53 | 355.99 | 451.75 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 24.83 | 36.43 | 34.52 | 68.97 | 76.54 | 87.20 | 110.65 | 140.41 | 178.18 | 226.11 |
| Capital Expenditure | -180.84 | -256.81 | -218.79 | -201.66 | -156.20 | -426.54 | -541.27 | -686.87 | -871.62 | -1,106.08 |
| Free Cash Flow | -156 | -220.38 | -184.27 | -132.69 | -79.66 | -339.35 | -430.62 | -546.45 | -693.44 | -879.97 |
| WACC | ||||||||||
| PV LFCF | -325.45 | -396.08 | -482.03 | -586.64 | -713.95 | |||||
| SUM PV LFCF | -2,504.15 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 4.27 |
| Free cash flow (t + 1) | -897.56 |
| Terminal Value | -39,540.29 |
| Present Value of Terminal Value | -32,080.64 |
Intrinsic Value
| Enterprise Value | -34,584.78 |
|---|---|
| Net Debt | 690.10 |
| Equity Value | -35,274.89 |
| Shares Outstanding | 65.46 |
| Equity Value Per Share | -538.86 |